These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 3471082

  • 1. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG.
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [Abstract] [Full Text] [Related]

  • 2. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG.
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [Abstract] [Full Text] [Related]

  • 3. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
    Knauf H, Mutschler E.
    Arzneimittelforschung; 2005 Apr; 55(1):1-14. PubMed ID: 15727159
    [Abstract] [Full Text] [Related]

  • 5. Dissociation of effects of xanthine analogs on renal prostaglandins and renal excretory function in the awake rat.
    Baer PG, Armstrong EL, Cagen LM.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):600-4. PubMed ID: 6581288
    [Abstract] [Full Text] [Related]

  • 6. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM.
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [Abstract] [Full Text] [Related]

  • 7. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE, Sørensen AM, Petersen JS, Andreasen F, Christensen S.
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [Abstract] [Full Text] [Related]

  • 8. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS, Park GT, Kim YH, Shim SG, Kim JB, Lee OY, Choi HS, Hahm JS, Lee MH.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [Abstract] [Full Text] [Related]

  • 9. Relationship between urinary prostaglandin (PGE2 and PGF2 alpha) and sodium excretion in various stages of chronic liver disease.
    Wernze H, Müller G, Goerig M.
    Adv Prostaglandin Thromboxane Res; 1980 Dec; 7():1089-96. PubMed ID: 7369021
    [Abstract] [Full Text] [Related]

  • 10. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
    Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M.
    Hepatology; 1998 Sep; 28(3):683-8. PubMed ID: 9731559
    [Abstract] [Full Text] [Related]

  • 11. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G.
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [Abstract] [Full Text] [Related]

  • 12. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 13. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [Abstract] [Full Text] [Related]

  • 14. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
    Mansurov KhKh, Dustov AD.
    Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
    [Abstract] [Full Text] [Related]

  • 15. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J, Kent JD, López-Parra M, Escolar G, Ruiz-Del-Arbol L, Ginès P, Jiménez W, Vucelic B, Arroyo V.
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [Abstract] [Full Text] [Related]

  • 16. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK.
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF.
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [Abstract] [Full Text] [Related]

  • 18. Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins.
    Daskalopoulos G, Kronborg I, Katkov W, Gonzalez M, Laffi G, Zipser RD.
    Am J Kidney Dis; 1985 Oct; 6(4):217-21. PubMed ID: 3901735
    [Abstract] [Full Text] [Related]

  • 19. Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
    Hattori K, Hasumura Y, Takeuchi J.
    Scand J Gastroenterol; 1984 Sep; 19(6):844-8. PubMed ID: 6393317
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.